A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study with an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin, or Basal Insulin, or Both (SURPASS-PEDS)

Is this Study for You?

Let's Get Started!

Details
Age

Child

Type of Study

Treatment

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Philip Zeitler,  MD, PhD

Philip Zeitler, MD, PhD

Study ID

Protocol Number: 22-0513

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers